Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Oxford Open Immunology
|
February 27, 2023
Vaccine responses in ageing and chronic viral infection
Chloe Rees-Spear, Laura E McCoy
NPJ Vaccines
|
May 2, 2026
High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies
Chloe Rees-Spear, Olivia Payne, Emma Touizer, et al.
Kidney International Reports
|
May 4, 2021
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection
Luke Muir, Aneesa Jaffer, Chloe Rees-Spear, et al.
Iscience
|
March 29, 2024
High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization
Peter Thomas, Chloe Rees-Spear, Sarah Griffith, et al.
Frontiers in Immunology
|
June 13, 2024
TIGIT<sup>+</sup>Tfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre
Natalie M Edner, Luke P Houghton, Elisavet Ntavli, et al.
The Journal of Clinical Investigation
|
November 29, 2021
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
Anna Jeffery-Smith, Alice R Burton, Sabela Lens, et al.
Critical Care Explorations
|
August 13, 2021
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
Nishkantha Arulkumaran, Timothy Arthur Chandos Snow, Adarsh Kulkarni, et al.
Plos Pathogens
|
January 16, 2026
Multifaceted B cell response to transient HIV viremia in elite controllers
Luke Muir, Ondrej Suchanek, Peter Thomas, et al.
Scientific Reports
|
November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Cell Reports
|
March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Oxford Open Immunology
|
February 27, 2023
Vaccine responses in ageing and chronic viral infection
Chloe Rees-Spear, Laura E McCoy
NPJ Vaccines
|
May 2, 2026
High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies
Chloe Rees-Spear, Olivia Payne, Emma Touizer, et al.
Kidney International Reports
|
May 4, 2021
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection
Luke Muir, Aneesa Jaffer, Chloe Rees-Spear, et al.
Iscience
|
March 29, 2024
High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization
Peter Thomas, Chloe Rees-Spear, Sarah Griffith, et al.
Frontiers in Immunology
|
June 13, 2024
TIGIT<sup>+</sup>Tfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre
Natalie M Edner, Luke P Houghton, Elisavet Ntavli, et al.
The Journal of Clinical Investigation
|
November 29, 2021
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
Anna Jeffery-Smith, Alice R Burton, Sabela Lens, et al.
Critical Care Explorations
|
August 13, 2021
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
Nishkantha Arulkumaran, Timothy Arthur Chandos Snow, Adarsh Kulkarni, et al.
Plos Pathogens
|
January 16, 2026
Multifaceted B cell response to transient HIV viremia in elite controllers
Luke Muir, Ondrej Suchanek, Peter Thomas, et al.
Scientific Reports
|
November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Cell Reports
|
March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Page
of 2